
Overview
Nuklover is a company that supports nuclear medicine and radiopharmacy by providing products such as germanium-gallium generators, radiopharmaceutical synthesis modules, and quality control equipment for radiopharmaceuticals. They also offer isotopes like 161-terbium and oxygen-18 enriched water, along with filtration systems for nuclear medicine.
Financials
From the notes
| Profit allocation | No decision |
Filing timeliness
The financial statement for 2025 was filed on time.
- 202510/06/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Germanium-gallium generators
- Radiopharmaceutical synthesis modules
- Radiopharmaceutical quality control equipment
- Terbium-161 isotope
- Oxygen-18 enriched water
- Nuclear medicine filtration systems
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Analytics
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Ałła Brzezowska age 47 | 45 | $1,215.56 | 90% |
Jan Franciszek Brzezowski age 21 | 5 | $135.06 | 10% |
Magdalena Ałła Brzezowska and Jan Franciszek Brzezowski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-09-24.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nucmed sp. z o.o. | $1,715,159.85 | nucmed.pl | ||
| Kunctrade sp. z o.o. | $720,968.35 | kunctrade.com | ||
| Hemab Polska sp. z o.o. | $639,152.50 | hemab.pl | ||
| Irimed sp. z o.o. sp. k. | $361,870.36 | irimed.pl | ||
| Paramedica Polska sp. z o.o. | $340,878.31 | paramedica.pl | ||
| Medcell sp. z o.o. | $339,369.93 | medcell.pl | ||
| Polrentgen sp. z o.o. | $259,719.20 | polrentgen.pl | ||
| Sprzęt Laboratoryjny I Medyczny Labpartner Kbs sp. z o.o. | $198,554.16 | lab-partner.pl | ||
| Alab-Med sp. z o.o. | $166,094.09 | alab.com.pl | ||
| Aveus Instruments sp. z o.o. | $75,878.13 | aveusinstruments.com.pl |
FAQ
Last updated: 2026-07-21
